Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Smith

Showing results (11-20 of 303) with videos related to

Pageof 31
Sort By:
Arthritis Care & Research|April 28, 2011
Cutaneous vasculopathy associated with cocaine useNataliya Milman, C Douglas Smith
Clinical Therapeutics|August 6, 2010
Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinibBrady Stein, B Douglas Smith
Stem Cell Reviews and Reports|October 13, 2016
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling PathwaysOhad Oren, B Douglas Smith
Scandinavian Journal of Caring Sciences|July 31, 2023
Exploring informal caregivers' well-being during COVID-19 through online discussion forumsAnni Lindroos, Nicola Douglas-Smith
Clinical Therapeutics|February 3, 2019
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid LeukemiaJonathan Webster, B Douglas Smith
Journal of Religion and Health|July 4, 2025
The Experience of Self-Compassion in Church of England Working Clergy: An Exploratory Qualitative Pilot Study Conducted in EnglandBelinda Norrington, Nicola Douglas-Smith
Regional Anesthesia and Pain Medicine|December 23, 2011
The safety of suprascapular nerve blockE Michael Shanahan, Malcolm Douglas Smith
Leukemia Research|February 24, 2006
Developmental clinical trials: building one step at a timeJudith E Karp, B Douglas Smith
Current Hematologic Malignancy Reports|April 19, 2013
Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?Arati V Rao, B Douglas Smith
Leukemia Research|August 19, 2003
Ribonucleotide reductase: an old target with new potentialB Douglas Smith, Judith E Karp
Pageof 31

Showing results (11-20 of 303) with videos related to

Sort By:
Pageof 31
Arthritis Care & Research|April 28, 2011
Cutaneous vasculopathy associated with cocaine useNataliya Milman, C Douglas Smith
Clinical Therapeutics|August 6, 2010
Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinibBrady Stein, B Douglas Smith
Stem Cell Reviews and Reports|October 13, 2016
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling PathwaysOhad Oren, B Douglas Smith
Scandinavian Journal of Caring Sciences|July 31, 2023
Exploring informal caregivers' well-being during COVID-19 through online discussion forumsAnni Lindroos, Nicola Douglas-Smith
Clinical Therapeutics|February 3, 2019
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid LeukemiaJonathan Webster, B Douglas Smith
Journal of Religion and Health|July 4, 2025
The Experience of Self-Compassion in Church of England Working Clergy: An Exploratory Qualitative Pilot Study Conducted in EnglandBelinda Norrington, Nicola Douglas-Smith
Regional Anesthesia and Pain Medicine|December 23, 2011
The safety of suprascapular nerve blockE Michael Shanahan, Malcolm Douglas Smith
Leukemia Research|February 24, 2006
Developmental clinical trials: building one step at a timeJudith E Karp, B Douglas Smith
Current Hematologic Malignancy Reports|April 19, 2013
Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?Arati V Rao, B Douglas Smith
Leukemia Research|August 19, 2003
Ribonucleotide reductase: an old target with new potentialB Douglas Smith, Judith E Karp
Pageof 31